Hacker News new | ask | show | jobs
by bb88 957 days ago
And that's what's available today.

Lilly has the so-called "Triple-G" shot in trials right now. Retartrutide shows even better weight loss potential than Tirzepatide

1 comments

To what extent do you think this addresses root causes? Like, does it physiologically compel them to be less hungry or what?
Yes, that’s exactly what it does. My hunger is absolutely diminished, and my reward feedback from eating are also diminished.
Is developing tolerance/dose escalation a prescient issue here?
People move through the different doses at different speeds, and most people seem to find a stopping, long-term dose, but also there are people complaining that they’ve hit 15 and it’s starting to wear off. There’s also not a well-developed stopping protocol, other than “this is a drug for life but maybe start spreading out dosage”.